( February 14, 2025, 10:23 AM EST) -- WILMINGTON, Del. — A Delaware federal judge said in unsealed finding of facts and conclusions of law that a plaintiff biopharmaceutical company failed to support its argument that a defendant company infringed on its patented eye medication product; the judge also found, though, that the defendant company failed to show that claims of the patents at issue were invalid....